The Chicago Entrepreneur

[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width="100%" palette="financial-light"]
Menu
Top Stories

Biogen and Belgian partner UCB announce positive data from late-stage trial of lupus treatment

Biogen Inc.’s stock rose 2% early Tuesday, after the company and Belgian partner UCB announced positive results in a late-stage trial

Previous post Warren Buffett is a fan of energy stocks. Here’s one more strong buy signal.
Next post Would a 60% tariff on Chinese imports hurt China or the U.S. more?

More Stories